Abstract
Objective
To assess symptoms and objective parameters of autonomic dysfunction (AD) in patients with ANCA-associated vasculitides.
Methods
Symptoms and objective parameters of AD were assessed in patients with ANCA-associated vasculitis and in age-matched healthy controls. Autonomic symptoms were explored by COMPASS31, a validated questionnaire addressing symptoms of six autonomic domains (orthostatic, vasomotor, secretomotor, gastrointestinal, pupillomotor, and bladder dysfunction). Objective autonomic parameters consisted of expiratory/inspiratory (E/I) ratio during the deep breathing test (DBT), blood pressure response to cold pressor test (CPT), and skin conductance changes during mental arithmetic.
Results
27 patients and 27 healthy controls have been enrolled. 27 patients and 27 controls completed COMPASS31. 21 patients and 18 controls underwent objective autonomic testing. Vasculitis patients had significantly higher COMPASS31 total scores than controls (median 10.4 vs 3.0; p = 0.005). In the sub-domain analysis, significant differences were seen in the vasomotor and the bladder domain (p = 0.004; p < 0.001, respectively). No correlation was found between COMPASS31 score and disease duration, number of affected organs, or Birmingham vasculitis activity score (BVAS). There was no significant difference in any of the objective autonomic parameters between patients and controls. In a subgroup analysis, no difference in objective autonomic parameters was found between patients with active disease (n = 12) and patients in remission (n = 7).
Conclusion
Patients with ANCA-associated vasculitides commonly have symptoms of autonomic dysfunction that are independent of disease duration and disease severity. However, at least in this single-centre observation, there was no evidence of impaired autonomic regulation in three autonomic function tests in vasculitis patients.
Similar content being viewed by others
References
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381
Alba MA, Moreno-Palacios J, Beca S, Cid MC (2015) Urologic and male genital manifestations of granulomatosis with polyangiitis. Autoimmun Rev 14:897–902
Bernardi L, Ricordi L, Lazzari P, Solda P, Calciati A, Ferrari MR, Vandea I, Finardi G, Fratino P (1992) Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 86:1443–1452
Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB (2004) Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109:1718–1723
Bruce IN, Harris CM, Nugent A, McDermott BJ, Johnston GD, Bell AL (1997) Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis. Scand J Rheumatol 26:318–324
Cohen Tervaert JW (2013) Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. Best Pract Res Clin Rheumatol 27:33–44
Dufour JF, Le Gallou T, Cordier JF, Aumaitre O, Pinede L, Aslangul E, Pagnoux C, Marie I, Puechal X, Decaux O, Dubois A, Agard C, Mahr A, Comoz F, Boutemy J, Broussolle C, Guillevin L, Seve P, Bienvenu B (2012) Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine (Baltimore) 91:67–74
Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B (2009) Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis. Arthritis Rheum 60:1187–1192
Filer AD, Gardner-Medwin JM, Thambyrajah J, Raza K, Carruthers DM, Stevens RJ, Liu L, Lowe SE, Townend JN, Bacon PA (2003) Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 62:162–167
Gang Y, Malik M (2002) Heart rate variability in critical care medicine. Curr Opin Crit Care 8:371–375
Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F, Valcke JC, Godeau P (1995) Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore) 74:152–161
Laederach-Hofmann K, Mussgay L, Ruddel H (2000) Autonomic cardiovascular regulation in obesity. J Endocrinol 164:59–66
Louthrenoo W, Ruttanaumpawan P, Aramrattana A, Sukitawut W (1999) Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. QJM 92:97–102
Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT (2008) Autonomic nervous symptoms in primary Sjogren’s syndrome. Rheumatology (Oxford) 47:914–919
Morgan MD, Turnbull J, Selamet U, Kaur-Hayer M, Nightingale P, Ferro CJ, Savage CO, Harper L (2009) Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum 60:3493–3500
Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF (2012) Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome. Ann Rheum Dis 71:1973–1979
Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33:4–9
Nomura A, Kishimoto M, Takahashi O, Deshpande GA, Yamaguchi K, Okada M (2013) Prolongation of heart rate-corrected QT interval is a predictor of cardiac autonomic dysfunction in patients with systemic lupus erythematosus. Rheumatol Int 34(5):643–647
Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima JA, Bluemke DA (2013) Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (diabetes control and complications trial/epidemiology of diabetes interventions and complications). J Am Coll Cardiol 61:447–454
Shalimar Handa R, Deepak KK, Bhatia M, Aggarwal P, Pandey RM (2006) Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 26:837–840
Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87:1196–1201
Stojanovich L (2009) Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 8:569–572
Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Hoglund P, Javaid MK, Jayne D, Mukhtyar C, Westman K, Davis JC Jr, Hoffman GS, McCune WJ, Merkel PA, St Clair EW, Seo P, Spiera R, Stone JH, Luqmani R (2011) A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken) 63:588–596
Wang CC, Weng TI, Wu ET, Wu MH, Yang RS, Liu SH (2013) Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide. Toxicol Sci 131:302–310
Ziegler D, Strom A, Strassburger K, Nowotny B, Zahiragic L, Nowotny PJ, Carstensen-Kirberg M, Herder C, Szendroedi J, Roden M (2015) Differential patterns and determinants of cardiac autonomic nerve dysfunction during endotoxemia and oral fat load in humans. PLoS One 10:e0124242
Zinger H, Sherer Y, Shoenfeld Y (2009) Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Clin Rev Allergy Immunol 37:20–28
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflicts of interest.
Additional information
P. Moog and O. Eren both authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Moog, P., Eren, O., Witt, M. et al. Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis. Clin Auton Res 26, 279–285 (2016). https://doi.org/10.1007/s10286-016-0364-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-016-0364-8